Psychotherapy initiation is associated with discontinuation of psychotropic medications without dose escalation: a ten-year real-world cohort study (2014-2024) - Scorecard - MDSpire
Advertisement
Psychotherapy initiation is associated with discontinuation of psychotropic medications without dose escalation: a ten-year real-world cohort study (2014-2024)
Clinical Scorecard: Association Between Starting Psychotherapy and Reduction of Psychotropic Medication Use Without Dose Increase: A Ten-Year Real-World Cohort Analysis (2014-2024)
At a Glance
Category
Detail
Condition
Psychotropic Medication Use
Key Mechanisms
Psychotherapy facilitates self-efficacy, adaptive emotional regulation, and cognitive restructuring.
Target Population
Patients with active prescriptions for benzodiazepines or antidepressants initiating psychotherapy.
Care Setting
Public mental health care
Key Highlights
Median number of psychotropic medications decreased from 5 to 2 (p < 0.001).
Benzodiazepine use declined from 87.6% to 67.5% (p < 0.001).
Antidepressant use decreased from 81.8% to 68.8% (p < 0.001).
Men were more likely than women to discontinue benzodiazepines (odds ratio 1.27).
Simplification of medication regimens increased with age.
Guideline-Based Recommendations
Diagnosis
Evaluate patients with anxiety and mood disorders for psychotherapy initiation.
Management
Consider psychotherapy as a strategy for reducing psychotropic medication use.
Monitoring & Follow-up
Assess changes in medication regimens post-psychotherapy initiation.
Risks
Monitor for potential adverse effects of polypharmacy.
Patient & Prescribing Data
86,502 patients with psychotropic prescriptions.
Psychotherapy initiation is associated with a significant reduction in the number of psychotropic medications without increasing total dose.
Clinical Best Practices
Integrate psychotherapy into treatment plans for patients on psychotropic medications.
Utilize dispensing data to monitor medication use patterns.
